Drixece (salicylic acid/sulfacetamide sodium)
Acne Antibiotics Topical Suspension, Topical (ML)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Generic name: salicylic acid/sulfacetamide sodium
Drug class: Acne Antibiotics
Therapeutic class: Dermatological
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Drixece
Indications
No indications are available for this drug.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
Severe Interaction: Action is required to reduce the risk of severe adverse interaction.
Topical Sodium Sulfacetamide/Topical Silver
SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction.
MECHANISM OF ACTION: Topical sodium sulfacetamide and topical silver are physically incompatible.(1,2)
CLINICAL EFFECTS: Concurrent application of topical sodium sulfacetamide and topical silver preparations may result in decreased clinical effectiveness of the products.(1,2)
PREDISPOSING FACTORS: None determined.
PATIENT MANAGEMENT: Avoid using topical silver preparations on the same location as topical sodium sulfacetamide products.(1,2)
DISCUSSION: Topical sodium sulfacetamide and topical silver are physically incompatible.(1,2)
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Aspirin exacerbated respiratory disease
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemoglobin H disease
- Hemolytic anemia from pyruvate kinase and g6PD deficiencies
There are no severe contraindications for this drug.
- Peripheral vascular disease
Adverse reactions
There is no enhanced messaging for this drug.
Rare or Very Rare
- Agranulocytosis
- Anaphylaxis
- Blood dyscrasias
- Burns
- Dyspnea
- Erythema
- Facial edema
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency anemia
- Hepatic necrosis
- Hypersensitivity drug reaction
- Hypersensitivity drug reaction
- Periorbital edema
- Pharyngeal edema
- Pruritus of skin
- Skin irritation
- Skin rash
- Skin ulcer
- Stevens-johnson syndrome
- Superficial skin ulcer
- Syncope
- Systemic lupus erythematosus
- Throat constriction
- Toxic epidermal necrolysis
- Urticaria
More Frequent
- Stinging of skin
Less Frequent
- Dry skin
- Skin irritation
Rare or Very Rare
- Pruritus of skin
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.